Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
Nogová L, Reineke T, Brillant C, Sieniawski M, Rüdiger T, Josting A, Bredenfeld H, Skripnitchenko R, Müller RP, Müller-Hermelink HK, Diehl V, Engert A; German Hodgkin Study Group. Nogová L, et al. Among authors: muller rp, muller hermelink hk. J Clin Oncol. 2008 Jan 20;26(3):434-9. doi: 10.1200/JCO.2007.11.8869. Epub 2007 Dec 17. J Clin Oncol. 2008. PMID: 18086799
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, Boissevain F, De Wit M, Mezger J, Duhmke E, Willich N, Muller RP, Schmidt BF, Renner H, Muller-Hermelink HK, Pfistner B, Wolf J, Hasenclever D, Loffler M, Diehl V; German Hodgkin's Lymphoma Study Group. Engert A, et al. Among authors: muller rp, muller hermelink hk. J Clin Oncol. 2003 Oct 1;21(19):3601-8. doi: 10.1200/JCO.2003.03.023. Epub 2003 Aug 11. J Clin Oncol. 2003. PMID: 12913100 Clinical Trial.
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Eich HT, Staar S, Gossmann A, Hansemann K, Skripnitchenko R, Kocher M, Semrau R, Engert A, Josting A, Franklin J, Krug B, Diehl V, Müller RP; German Hodgkin Study Group. Eich HT, et al. Among authors: muller rp. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1121-7. doi: 10.1016/j.ijrobp.2003.08.033. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001253
The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients' imaging.
Eich HT, Staar S, Gossmann A, Engert A, Franklin J, Sieber M, Krug B, Diehl V, Lackner KJ, Müller RP; German Hodgkin Lymphoma Study Group. Eich HT, et al. Among authors: muller rp. Am J Clin Oncol. 2004 Jun;27(3):279-84. doi: 10.1097/01.coc.0000092701.47861.81. Am J Clin Oncol. 2004. PMID: 15170148 Clinical Trial.
Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
Eich HT, Haverkamp U, Engert A, Kocher M, Skripnitchenko R, Brillant C, Sehlen S, Dühmke E, Diehl V, Müller RP. Eich HT, et al. Among authors: muller rp. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):860-5. doi: 10.1016/j.ijrobp.2005.02.053. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15925455 Clinical Trial.
Lymphocyte-predominant and classical Hodgkin's lymphoma--comparison of outcomes.
Nogová L, Reineke T, Josting A, Müller-Hermelink HK, Eich HT, Behringer K, Müller RP, Diehl V, Engert A. Nogová L, et al. Among authors: muller rp, muller hermelink hk. Eur J Haematol Suppl. 2005 Jul;(66):106-10. doi: 10.1111/j.1600-0609.2005.00462.x. Eur J Haematol Suppl. 2005. PMID: 16007877
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, Herrmann R, Pfreundschuh M, Sieber M, Tesch H, Franke A, Koch P, de Wit M, Paulus U, Hasenclever D, Loeffler M, Müller RP, Müller-Hermelink HK, Dühmke E, Diehl V. Engert A, et al. Among authors: muller rp, muller hermelink hk. J Clin Oncol. 2007 Aug 10;25(23):3495-502. doi: 10.1200/JCO.2006.07.0482. Epub 2007 Jul 2. J Clin Oncol. 2007. PMID: 17606976 Clinical Trial.
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).
Eich HT, Gossmann A, Engert A, Kriz J, Bredenfeld H, Hansemann K, Skripnitchenko R, Brillant C, Pfistner B, Staar S, Diehl V, Müller RP; German Hodgkin Study Group. Eich HT, et al. Among authors: muller rp. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1187-92. doi: 10.1016/j.ijrobp.2007.04.035. Epub 2007 Aug 20. Int J Radiat Oncol Biol Phys. 2007. PMID: 17703895 Clinical Trial.
Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study group.
Eichenauer DA, Bredenfeld H, Haverkamp H, Müller H, Franklin J, Fuchs M, Borchmann P, Müller-Hermelink HK, Eich HT, Müller RP, Diehl V, Engert A. Eichenauer DA, et al. Among authors: muller rp, muller hermelink hk, muller h. J Clin Oncol. 2009 Dec 20;27(36):6079-85. doi: 10.1200/JCO.2008.20.2655. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901121
217 results